Friday, November 20, 2026

THE OCCUPATIONAL FACE OF MALE BREAST CANCER

Industrial Exposures, Cancer Risk, and the Need for Greater Occupational Health Awareness

A Two-Part Editorial Feature for the Male Breast Cancer Global Alliance (MBCGA)


PART I —COMMENTARY

The Men Behind the Diagnoses: Why Occupational History Deserves Greater Attention

By Cheri Ambrose | Male Breast Cancer Advocate

During the past 16 years, my involvement in male breast cancer advocacy has introduced me to hundreds of men whose experiences have shaped my understanding of this uncommon and frequently overlooked disease. Their circumstances differ considerably, yet many share a history of delayed recognition, limited public awareness, and uncertainty about the factors that may have contributed to their diagnoses. More recently, I have become particularly interested in an aspect of their medical histories that has not always received sufficient attention: their occupations.

Among the men I have encountered are welders, firefighters, electricians, automobile mechanics, chemical industry employees, and petroleum refinery workers. One individual spent approximately 36 years working in gasoline production. Another was employed as a chemist developing fragrances used in automobiles and commercial environments and is now living with metastatic male breast cancer. A third received training in nuclear technology, participated in volunteer firefighting, and subsequently worked in an institutional printing operation. Another combined employment in automotive manufacturing with firefighting and emergency medical services.

These accounts do not establish that occupational exposure caused their cancers. They do, however, raise legitimate questions about whether environmental and industrial histories are being adequately documented when men receive a breast cancer diagnosis.

CLICK TO ENLARGE

Male breast cancer is a relatively uncommon disease, and its recognized risk factors include inherited genetic susceptibility, hormonal conditions, advancing age, and family history. Nevertheless, the possibility that certain occupational exposures may contribute to risk deserves systematic investigation. In particular, long-term contact with industrial solvents, petroleum derivatives, combustion products, and other potentially carcinogenic substances warrants closer examination.

My concern extends beyond the scientific uncertainty surrounding these exposures. I have encountered men who appear reluctant to discuss possible occupational health concerns because of perceived consequences involving employers, disability benefits, pensions, or professional relationships. Although these concerns do not necessarily reflect actual employer practices, they may discourage open discussion and complicate efforts to document occupational histories.

My perspective has also been influenced by personal experience. My mother worked in a fiberglass manufacturing environment and subsequently died of lung cancer. Because she had smoked for many years, I initially attributed her illness primarily to tobacco exposure. With time, I began considering whether her occupational environment might also have contributed. I cannot establish such a relationship retrospectively, but the experience reinforced the importance of evaluating multiple possible influences on cancer development.

I believe employers, occupational health specialists, labor organizations, and cancer researchers have a shared responsibility to examine these questions. Appropriate exposure monitoring, transparent communication, improved protective practices, and long-term health surveillance are reasonable objectives regardless of whether a particular workplace exposure is ultimately linked to male breast cancer.

The purpose of occupational cancer advocacy should not be to assign responsibility without evidence. Rather, it should be to encourage the collection of reliable information, identify preventable hazards, and ensure that workers receive accurate guidance about potential health risks.

Scientific understanding evolves, and workplace practices should evolve accordingly. Procedures considered acceptable decades ago may no longer represent contemporary standards of occupational protection. Recognizing that possibility is not an indictment of industry; it is an essential component of responsible public health policy.

The men who have shared their experiences deserve serious consideration of the questions their histories raise. Their diagnoses cannot, by themselves, demonstrate occupational causation. However, their collective experiences provide a compelling rationale for further investigation.

My commitment is to ensure that these histories are documented, that appropriate research questions are pursued, and that men living with breast cancer are not excluded from broader discussions about occupational disease.

Ultimately, the objective is straightforward: individuals diagnosed with cancer deserve the opportunity to understand the factors that may have influenced their health, supported by scientific evidence rather than speculation.


PART II — OCCUPATIONAL HEALTH RESEARCH REPORT

Male Breast Cancer and Workplace Exposures: Epidemiological Evidence, Clinical Implications, and Research Priorities

Prepared for the Male Breast Cancer Global Alliance (MBCGA)

Introduction

Male breast cancer represents approximately 1% of breast cancer diagnoses in the United States. Established risk factors include pathogenic inherited variants, particularly involving BRCA2, family history, hormonal abnormalities, certain medical conditions, and advancing age. Occupational exposure has emerged as an additional area of epidemiological interest, although the evidence remains heterogeneous and insufficient to establish causation for many individual industries.

Investigations of occupationally associated male breast cancer have examined chemical exposures, industrial processes, ionizing radiation, and possible endocrine-disrupting agents. The relative rarity of the disease presents methodological challenges, including small case populations, incomplete historical exposure records, and difficulty separating occupational factors from genetic, hormonal, and environmental influences.

Occupational Categories and Potential Exposures

Several occupational populations warrant particular attention based on published epidemiological observations or plausible exposure pathways.

Firefighters may encounter complex mixtures of combustion products, polycyclic aromatic hydrocarbons, benzene, diesel exhaust, and other potentially carcinogenic substances. The International Agency for Research on Cancer has classified occupational exposure as a firefighter as carcinogenic to humans. However, this classification should not be interpreted as establishing a causal relationship with male breast cancer specifically.

Automotive mechanics and motor vehicle manufacturing personnel may experience prolonged exposure to petroleum products, solvents, degreasing compounds, exhaust emissions, and industrial coatings. Epidemiological investigations have reported associations between certain automotive occupations and male breast cancer, although findings are not uniform across studies.

Welders, foundry employees, and steelworkers represent another population of interest. Their occupational environments may involve metal fumes, combustion products, and sustained high-temperature conditions. Some European investigations have identified elevated male breast cancer odds among workers with higher cumulative welding-fume exposure, but these observations require further confirmation.

Additional occupational categories include petroleum refinery employees, chemical manufacturing personnel, industrial painters, printing workers, electricians, agricultural workers, aircraft maintenance technicians, and shipyard employees. These occupations encompass diverse exposures and should not be regarded as carrying equivalent or established male breast cancer risks.

Epidemiological Findings and Scientific Limitations

Research involving organic solvents has generated particular interest. A European multicenter case-control investigation reported an association between higher cumulative trichloroethylene exposure and male breast cancer, with approximately doubled odds in certain exposure categories. Such findings suggest a possible relationship but cannot independently establish causation.

Studies examining endocrine-disrupting chemicals have similarly raised questions about compounds capable of interfering with hormonal signaling. Because male breast tissue is responsive to estrogen-androgen balance, endocrine mechanisms represent a biologically plausible area of investigation.

Nevertheless, broader occupational studies, including Nordic population-based research, have not consistently demonstrated increased male breast cancer risk across the range of industrial exposures evaluated.

These inconsistencies reinforce the importance of distinguishing preliminary epidemiological associations from established occupational carcinogenic relationships.

Clinical Surveillance and Early Recognition

Occupational cancer prevention should prioritize exposure reduction through engineering controls, ventilation, appropriate protective equipment, industrial hygiene monitoring, and compliance with established workplace safety standards.

Clinical education represents a complementary priority. Men should be informed that persistent breast masses, nipple discharge, nipple retraction, or unexplained changes in breast tissue warrant timely medical assessment.

Diagnostic evaluation may include clinical examination, mammography, ultrasonography, and tissue biopsy when indicated. Routine breast cancer screening is not currently recommended for all men solely on the basis of employment in an occupation involving potential carcinogenic exposures. Individuals with established high-risk characteristics may require individualized assessment.

Medical infrared thermography has been proposed as a supplementary tool for investigating physiological temperature patterns and vascular responses. However, it has not been validated for male breast cancer screening or diagnosis and should not replace established diagnostic imaging or clinical evaluation.


Recommendations for a National Research Initiative

The Male Breast Cancer Global Alliance, in collaboration with the National Cancer Collective and occupational health partners, could facilitate a structured initiative examining the occupational histories of men diagnosed with breast cancer.

Such an initiative could incorporate standardized exposure questionnaires, occupational classification, documentation of employment duration, assessment of potential chemical and radiation exposures, and collaboration with epidemiologists and industrial hygienists.

Participation by firefighters’ associations, labor organizations, employers, occupational medicine departments, and cancer research institutions would improve access to relevant populations and strengthen opportunities for prospective investigation.

A coordinated research effort could also help identify gaps in occupational health education and determine whether specific worker populations would benefit from additional exposure monitoring or targeted medical awareness programs.

Conclusion

The relationship between occupational exposures and male breast cancer remains an important but incompletely understood area of cancer epidemiology. Although certain studies have identified associations involving solvents, automotive occupations, welding fumes, and other industrial exposures, the available evidence does not support broad conclusions that these occupations cause male breast cancer.

Further investigation is justified by the potential significance of preventable occupational exposures, the biological plausibility of certain mechanisms, and the limited attention historically devoted to male breast cancer in occupational health research.

A responsible public health response should combine scientific investigation, exposure prevention, clinical education, and systematic documentation of occupational histories. Such an approach would advance understanding without overstating current evidence and would provide a more substantive foundation for protecting the long-term health of working men.


Editorial & Medical Disclaimer

This article is intended for educational and informational purposes only and does not constitute medical advice, diagnosis, treatment recommendations, or endorsement of any product, manufacturer, or therapeutic intervention. References to erectile dysfunction (ED) treatments, emerging technologies, and market developments are presented for editorial review and should not be interpreted as evidence of clinical superiority, safety, or effectiveness. Individual outcomes may vary. Readers should consult a qualified healthcare professional before initiating or modifying treatment. Overture Health Press maintains editorial independence, and inclusion of any product or technology does not imply endorsement by the Women's Health Collaborative or Men's Health Network.


Scientific References

1. Villeneuve, S., et al. (2010). Occupation and occupational exposure to endocrine disrupting chemicals in male breast cancer: A case-control study in Europe. Occupational and Environmental Medicine, 67(12), 837–844. https://doi.org/10.1136/oem.2009.052175

2. Laouali, N., et al. (2018). Occupational exposure to organic solvents and risk of male breast cancer: A European multicenter case-control study. Scandinavian Journal of Work, Environment & Health, 44(3), 310–322. https://doi.org/10.5271/sjweh.3717

3. Cocco, P., et al. (1998). Case-control study of occupational exposures and male breast cancer. Occupational and Environmental Medicine, 55(9), 599–604. https://doi.org/10.1136/oem.55.9.599

4. Occupational exposures and male breast cancer: A nested case-control study in the Nordic countries. (2019). The Breast. https://pubmed.ncbi.nlm.nih.gov/31539869/

5. Lifetime exposure to welding fumes and risk of some rare cancers. (2022). American Journal of Epidemiology. https://doi.org/10.1093/aje/kwac123

6. Demers, P. A., et al. (2022). Carcinogenicity of occupational exposure as a firefighter. The Lancet Oncology. https://doi.org/10.1016/S1470-2045(22)00390-4

7. International Agency for Research on Cancer. (2023). Occupational Exposure as a Firefighter. IARC Monographs, Volume 132. https://publications.iarc.who.int/615

8. Weiss, J. R., Moysich, K. B., & Swede, H. (2005). Epidemiology of male breast cancer. Cancer Epidemiology, Biomarkers & Prevention, 14(1), 20–26.

9. American Cancer Society. Risk factors for breast cancer in men. https://www.cancer.org/cancer/types/breast-cancer-in-men/causes-risks-prevention.html

10. U.S. Food and Drug Administration. Breast cancer screening: Thermogram no substitute for mammogram. https://www.fda.gov/consumers/consumer-updates/breast-cancer-screening-thermogram-no-substitute-mammogram

Editorial note: Part I is a first-person adaptation of Cheri Ambrose’s interview and should be approved by her before publication under her byline. The scientific references are drawn from the supplied research materials and should undergo final bibliographic verification.

© 2026 Male Breast Cancer Global Alliance (MBCGA). All rights reserved.

GET CHECKED NOW: Protecting Those Who Protect Us

 Why First Responders Deserve More Options for Proactive Health Screening

An Op-Ed by Betsey A. Bowers


Founder, Bet-A-Therm Thermography | Diagnostic Screening Advocate, “Get Checked Now” Program | National Cancer Collective (NCC)

Every day, our firefighters, police officers, emergency medical technicians, and other first responders place themselves in harm’s way to protect our communities. They respond to emergencies, enter hazardous environments, encounter potentially dangerous substances, and endure extraordinary physical and emotional demands. Yet, when it comes to protecting their own health, too many wait until symptoms appear before seeking medical attention. I believe we need to change that mindset.

As the founder of Bet-A-Therm Thermography and an advocate for the National Cancer Collective’s “Get Checked Now” initiative, I am committed to encouraging a more proactive approach to health—particularly among the first responders serving our local communities.

My message is simple: You spend your career protecting others. Make time to protect yourself.

Understanding the Value of Early Assessment

First responders face occupational exposures that may increase their risk of certain cancers and other health conditions. Firefighters, for example, can encounter combustion byproducts, diesel exhaust, and hazardous chemicals. Long shifts, disrupted sleep, physical strain, and chronic stress may further complicate their overall health.

These realities make preventive healthcare, occupational health monitoring, and appropriate cancer screening especially important.

Fortunately, today’s healthcare landscape offers numerous ways to monitor health before serious problems become apparent. Depending on individual risk factors, these may include blood pressure assessments, laboratory testing, cardiovascular evaluations, skin examinations, and established cancer screening procedures.

I am particularly interested in expanding awareness of noninvasive assessment technologies, including medical infrared thermal imaging.

Where Thermal Imaging Fits

Thermal imaging is a noninvasive, radiation-free technology that measures temperature patterns across the surface of the body. By documenting variations in skin temperature, it can provide information about superficial thermal physiology that may be influenced by circulation, inflammation, and other biological processes.

It requires no injections, involves no physical compression, and can be performed without exposing the individual to ionizing radiation. These characteristics make thermography an interesting technology for physiological assessment and continued scientific investigation.

However, it is important to understand its limitations. Thermal imaging cannot independently diagnose cancer, identify the cause of an abnormal heat pattern, or replace established screening examinations such as mammography, colonoscopy, or low-dose CT when medically indicated.

For me, responsible advocacy means helping individuals understand both the possibilities and limitations of available technologies.

Bringing Health Awareness Into Our Communities

One of my priorities is reaching local first responders where they work and serve. Through educational partnerships, community outreach, and initiatives such as NCC’s “Get Checked Now,” I hope to encourage conversations among firefighters, police departments, emergency personnel, occupational health professionals, and healthcare providers.

We should be asking important questions: Are our first responders receiving appropriate preventive examinations? Do they understand their occupational risks? Are they aware of available screening services? Are they following up on concerning symptoms?

These conversations can lead to meaningful action.

A Commitment to Prevention

I believe proactive healthcare should become as familiar to first responders as maintaining their equipment, checking their protective gear, and preparing for the next emergency.

No single examination can provide every answer. The greatest value comes from combining health education, evidence-based screening, appropriate medical guidance, and individual responsibility.

Through “Get Checked Now,” my goal is to help make preventive health awareness part of the culture of those who serve.

Because the men and women who answer our calls for help deserve something equally important in return: a community that encourages them to take care of themselves. Protect those who protect us. Get informed. Get evaluated. GET CHECKED NOW.


Educational Disclaimer: Medical infrared thermography is not an established standalone cancer screening or diagnostic method and should not replace recommended medical examinations. First responders should consult qualified healthcare professionals regarding occupational exposures, individual risk factors, and appropriate screening recommendations.


RELATED ARTICLE: Men's Health Report: THERMAL SCANNING OF THE CHEST/ READING THE INVISIBLE- The Science and Clinical Interpretation of Thoracic Infrared Thermology: https://healthtechreporter.blogspot.com/2026/11/mens-health-report-thermal-scanning-of.html

Medical infrared thermology examines patterns of heat emitted from the body’s surface. Unlike mammography, ultrasound, or MRI, which principally depict anatomical features, thermography records skin-surface thermal distribution that can reflect superficial blood flow, autonomic regulation, and other physiological influences. The distinction is important: a thermal image does not directly show a tumor or identify malignant cells.

..................................................................................................................................................

About the Author 

Betsey A. Bowers is a healthcare entrepreneur and thermography professional with more than 30 years of experience in patient services and medical practice operations. Specializing in infrared thermal imaging since 2002, she founded Bet A Therm in 2020 to expand access to mobile thermography services throughout Ohio. Working collaboratively with healthcare providers and medical imaging specialists, Betsey promotes noninvasive physiological assessment, preventive health education, and patient-centered care. As an advocate for the National Cancer Collective's “Get Checked Now” initiative, she is especially committed to advancing health awareness and proactive medical evaluation among first responders and underserved communities.


Tuesday, November 17, 2026

MEN'S HEALTH: Thermal Imaging of the Chest

The Science and Clinical Interpretation of Thoracic Infrared Thermology

Advancing Men’s Breast Health: Thermal Imaging, Vascular Assessment, and the Potential Role of Functional Imaging in Male Breast Cancer Evaluation. 
Educational analysis of actual reports interpreted by Dr. Phil Hoekstra, DABT 

PROLOGUE: Bringing Men's Breast Health Into Focus

While breast cancer has traditionally been associated with women's health, growing awareness of male breast cancer—and evidence of increasing incidence in some populations—underscores the importance of expanding the conversation to include men. Although male breast cancer remains relatively uncommon, its consequences can be significant, particularly when symptoms are overlooked or diagnosis is delayed. This article deliberately focuses on MEN'S BREAST HEALTH, SCREENING AWARENESS, AND THE EXPLORATION OF THORACIC INFRARED THERMOLOGY as a potential adjunctive physiological assessment technology. Through the clinical observations and interpretations of Dr. Phil Hoekstra, we examine how thermal imaging measures vascular activity, temperature variations, and physiological patterns across the male chest. Importantly, thermography is not an established screening test for male breast cancer and cannot replace appropriate clinical evaluation, mammography, or ultrasound.

Our emphasis on men is not intended to diminish the extraordinary progress, public awareness, and scientific achievements associated with women's breast cancer screening and diagnostic imaging. Rather, it recognizes that men deserve greater visibility in breast health education, research, and early detection initiatives. The extensive experience gained through women's breast imaging provides an important foundation for understanding the possibilities and limitations of complementary technologies. For readers interested in exploring the broader application of breast imaging in women's health, we invite you to review our companion educational feature: [Women's Breast Cancer Imaging: An Adjunctive Review — Click Here] 


Introduction: Understanding What the Human Eye Cannot See

Medical infrared thermology examines patterns, levels and behavior of heat emitted from the body’s surface. Unlike mammography, ultrasound, or MRI, which principally depict anatomical features, thermography reveals skin-surface thermal features that reflect superficial blood flow, autonomic regulation, and other physiological influences. The distinction is important: a thermal image does not directly show a tumor or identify malignant cells.

Men’s breast health deserves greater clinical and public attention. Although male breast cancer is uncommon, men may overlook breast or nipple changes or delay seeking evaluation. Two anonymized thoracic examinations interpreted by Dr. Phil Hoekstra illustrate how the laboratory measures and classifies thermal patterns across the male chest. One report describes a persistent abnormal (TH-4, see below) pattern on one side; the other describes normal (TH-1, see below) findings. These reports offer useful examples of objective patho-physiological documentation, not evidence that thermography is an effective standalone screening test for male breast cancer.

How the Technology Identifies and Reads Thermal Patterns: Infrared cameras detect infrared energy emitted by the skin and convert it into quantitative surface-temperature measurements. There is no objective color to infrared energy so calibrated color palettes are software generated enabling an intuitive association of warmer and cooler colors that will correspond to temperature ranges on each image’s scale, not to particular diseases. Both reports include anterior and lateral views, temperature reference points, and replicate imaging sets. The interpreter considers regional symmetry, focal thermal differences, the configuration and extent of superficial vascular patterns, the distribution of thermal emissions and the adaptive response of the emission levels to a physiologic challenge.

click to enlarge

A valuable distinction is between what the instrument measures and what the clinician infers. The camera measures surface infrared emission; descriptions such as hyperthermia, asymmetry, and vascular pattern characterize the resulting image. Assertions about possible underlying malignancy are interpretations that require independent clinical confirmation.

The Functional Vascular Challenge: Both reports describe two replicate sets of three high-resolution infrared images. The second set was acquired after approximately one minute of hand immersion in cool water near 53 o F (11°C). The laboratory uses this controlled stimulus to assess adaptive changes in blood flow. Cooling challenge triggers sympathetic vasoconstriction, reducing skin blood flow and altering temperature. Comparing images before and after the challenge offers a functional observation beyond a single static thermogram.

The reports describe the cool challenge as intended to distinguish normally regulated vessels from potentially unregulated hyperemia. Nevertheless, thermal responses can be affected by autonomic variation, certain medications, ambient conditions, and acquisition technique. A response pattern is not a cancer-specific test (pathognomonic).

Report A: Persistent Asymmetric Findings - The first report compares examinations from 2020, 2022, and 2023. It describes an asymmetric, moderately hyperthermic, diffuse vascular pattern in the peri-areolar and upper right pectoral region. The laboratory identified no significant thermal signs on the opposite side. Post-challenge images nevertheless showed bilaterally symmetric adaptive attenuation of emission levels after the cool challenge, indicating that the observed asymmetry and the cooling response were considered together rather than in isolation.

The right side received TH-4 and the left TH-1 across all three study dates. The interpreter described relatively small interval changes in vascular extent, caliber, and thermal emission and considered the persistence of the pattern relevant to the assessment. The report associated the TH-4 pattern with an approximate 65% risk of malignant disease. This is the laboratory’s stated risk estimate, not a confirmed diagnosis or an independently verified probability for this individual. The report recommended further objective evaluation and a comparative restudy in 90–120 days.

Report B: Symmetrical Thermal Findings: The second report found essentially symmetrical thermal patterns across both pectoral regions, without significant focal or complex vascular asymmetries or disproportionate whole-region hyperthermia. Following the cold challenge, both sides demonstrated symmetric adaptive attenuation. The laboratory assigned TH-1 to both regions and recommended annual comparative thermology.

A critical qualification appears in this report: the images did not conform to standardized protocols. That limitation matters when interpreting the strength and reproducibility of the findings. TH-1 means no qualifying thermological signs were identified under the laboratory’s criteria; it does not rule out all chances of cancer or other breast pathology.


Inside the Reports: What the Observations Add - Selected brief excerpts show the difference between measurable findings and their clinical interpretation:

Vascular configuration — Report A, p. 2 “An asymmetric, moderately hyperthermic, diffuse and vascular pattern”

Value: documents the location and character of a surface thermal asymmetry. Limitation: cannot establish its underlying cause.

Dynamic response — Report A, p. 2  “symmetric and adaptive attenuation of the emission levels”

Value: describes physiological change following a defined stimulus, adding a second dimension to static imaging.

Longitudinal comparison — Report A, p. 2 “increases of extent, caliber and relative emission levels”

Value: records changes in image characteristics over time, although evolution is not specific to malignancy.


Normal classification — Report B, p. 1  “does not indicate any thermology Signs or Criteria”

Value: illustrates how an examination without qualifying abnormalities is categorized under this laboratory’s framework.

 



The TH Scoring System: What the Numbers Mean-  The reports reference the Marseille thermological classification system, developed in the 1970s, which grades findings from TH-1 to TH-5 using defined thermal signs and criteria. These two examples substantiate the following narrower interpretation: TH-1 denotes no qualifying concerning signs, whereas TH-4 denotes multiple signs that the laboratory considers associated with increased malignancy risk. The reports do not supply a full criterion-by-criterion definition of TH-2, TH-3, or TH-5; those categories should not be reconstructed from these examples. TH scores are similar but not exactly interchangeable with BI-RADS categories.

 

Characteristic

Report A

Report B

Right pectoral TH score

TH-4

TH-1

Left pectoral TH score

TH-1

TH-1

Thermal distribution

Asymmetric right-sided pattern

Essentially symmetrical

Post-challenge response

Adaptive attenuation

Symmetric adaptive attenuation

Temporal comparison

Three examinations

No prior comparison listed

Laboratory conclusion

Concerning thermological signs

No qualifying thermological signs


Clinical Value and Important Boundaries - These examinations demonstrate several potential documentary strengths: noninvasive measurement of skin-surface temperature, comparison between anatomical sides, observation of dynamic cooling responses, and longitudinal review of thermal patterns. They also demonstrate why interpretation must be cautious. Inflammation, infection, benign vascular processes, and acquisition variability can produce variant thermal findings that are not malignant. Conversely, an apparently normal thermal study cannot exclude a lesion.

Thermography is an US Dept HHS listed adjunctive screening modality with FDA regulated equipment but not recognized as a replacement for mammography, and evidence does not establish it as an effective standalone breast cancer screening method in men. Any palpable lump, nipple discharge, nipple inversion, skin change, or other suspicious symptom warrants clinical examination and appropriate established diagnostic imaging, commonly diagnostic mammography and/or targeted ultrasound as indicated.


Conclusion: A Responsible Role in Men’s Breast Health

Dr. Hoekstra’s contrasting reports help explain how a laboratory transforms thermal measurements into descriptive findings and TH classifications. The TH-4 case shows how persistent regional asymmetry and vascular characteristics can prompt concern and further evaluation; the bilateral TH-1 case illustrates the absence of qualifying signs within the same interpretive framework. Neither classification independently diagnoses or excludes cancer.

For men’s breast health, the principal present value of these examples is educational: they encourage attention to male chest and breast changes and show how functional observations differ from structural diagnosis. Whether standardized infrared thermology can contribute clinically useful supplementary information to male breast cancer pathways remains a research question. Awareness, timely evaluation of symptoms, and evidence-based diagnostic care must remain central.



Source and Editorial Notes
Primary sources: two anonymized reports titled “Analysis of Thoracic Thermology,” interpreted by Dr. Phil Hoekstra, DABT (2023, five pages; 2026, three pages). All patient names, dates of birth, scan identifiers, and referring clinician information have been omitted. Selected short excerpts are reproduced for critical educational commentary; original thermograms and proprietary page layouts are not reproduced.

IMAGE CREDITS & SPECIAL ACKNOWLEDGMENTS

Image Credits & Courtesy

Original clinical thermographic images, medical interpretations, and supporting diagnostic materials are the intellectual property of Therma-Scan Reference Laboratory, LLC, and are presented courtesy of Dr. Phil Hoekstra and Betsey Bowers of Bet-A-Therm Thermography. Educational illustrations and graphic adaptations are included to support public understanding of infrared thermology and men's breast health. All rights to original clinical materials remain with their respective owners.

SPECIAL THANKS- We extend our sincere appreciation to Dr. Phil Hoekstra, DABT, of Therma-Scan Reference Laboratory, LLC, for his scientific expertise, clinical interpretations, and contributions to the advancement of medical infrared thermology. His work provides the clinical foundation for this educational examination of thoracic thermal imaging and its potential relevance to men's breast health. Special recognition is also extended to Betsey Bowers, Founder of Bet-A-Therm Thermography, for her commitment to expanding access to noninvasive thermal imaging services, promoting public health education, and encouraging greater awareness of emerging and complementary physiological assessment technologies.


SPECIAL RECOGNITION OF OUR SPONSORS

Our gratitude goes to Cheri Ambrose of the Male Breast Cancer Global Alliance (MBCGA) and the National Cancer Collective (NCC) for their sponsorship and support of this educational publication. Their commitment to cancer awareness, patient advocacy, survivorship, and improved quality of life helps bring greater visibility to an often-overlooked concern: men's breast health and male breast cancer. Through collaboration among medical professionals, researchers, imaging specialists, and cancer advocacy organizations, we seek to encourage informed discussion, responsible scientific inquiry, and earlier recognition of concerning breast health symptoms among men.

This publication is intended for educational purposes. Thermography is not a substitute for established breast cancer screening or diagnostic procedures. Sponsorship and acknowledgment do not constitute endorsement of thermography as a validated standalone cancer screening method.


Medical disclaimer: This paper summarizes laboratory interpretations; it does not independently validate risk percentages, test performance claims, or clinical outcomes. Infrared thermography should not replace established breast cancer screening or diagnostic imaging.





Tuesday, January 20, 2026

TOXIN AWARENESS & DETOX PROTOCOLS

PHOTO NEWS SHOWCASE

  

NEWS REPORT

Montecito Fire Chiefs Meet With DETOXSCAN & F.A.C.E.S. Leadership to Discuss the Advancement of Toxin Awareness, Detox Protocols & Diagnostic Innovations for Firefighters

Montecito, CA — In a pivotal cross-agency meeting, DETOXSCAN Associate Editor Daniel Root and Lennard Goetze, President of F.A.C.E.S. (Firefighters Against Cancers & Exposures), convened with Fire Chief David Neels and Battalion Chief Shaun Davis of the Montecito Fire Department to address one of the most urgent crises in the modern fire service: occupational exposures and their lifelong health consequences.

Facilitated by integrative physician Dr. Leslie Valle Montoya—a clinical partner to DETOXSCAN and F.A.C.E.S. currently supporting firefighters responding to the Los Angeles wildfires—this meeting reinforced a shared mission: understanding the toxins firefighters face, implementing real detox pathways, and integrating new diagnostic tools such as point-of-care ultrasound (POCUS) and OligoScan toxin analysis.


A Shared Priority:
Occupational Exposure Is No Longer Optional - It’s a Crisis

From the outset, both agencies aligned on one reality: firefighters are exposed to an unprecedented and escalating mix of carcinogens, neurotoxins, combustion by-products, plastics, PFAS, VOCs, and heavy metals. Exposure is inevitable—but the long-term consequences don’t have to be.

Chief Neels emphasized that Montecito firefighters returning from recent wildfires—especially the Eaton and Palisades Fires—were already reporting concerns that triggered statewide attention and motivated early testing. Yet when well intended groups attempted to perform on-site blood draws at fire camps without adequate vetting, Chief Neels halted the effort for his personnel.


“It’s really tough for me… to support someone I don’t know drawing bloods at a fire camp that we have not vetted at all,” he explained. “We were not supportive. We needed to step back, bring our firefighters home, and do this properly.”  That caution marked a turning point: the department sought credible partners, validated methods and quantifiable testing—three pillars that DETOXSCAN and F.A.C.E.S. were built for.


  

Introducing Metal Scanning Innovation: OligoScan Toxin Mapping & POCUS

During the meeting, Goetze and Dr. Robert L. Bard (a brief guest participant) demonstrated the value of non-invasive toxin detection, including the OligoScan—a clinical spectrometer that scans tissue for heavy metals and elements in minutes.

 

Dr. Bard shared his own verified mercury results and explained how the device can:

·        detect metals such as mercury, lead, arsenic, and thallium,

·        quantify tissue levels rather than temporary blood or urine snapshots,

·        provide data within minutes without needles or lab shipping delays,

·        serve as a rapid screening tool after fire incidents.

For Montecito’s leadership, the possibility of on-scene or same-day toxin screening—immediately after exposure—was compelling. Equally striking was the introduction of POCUS (Point-of-Care Ultrasound), now available in handheld formats as small as a smartphone, with elastography and Doppler. POCUS is increasingly used for internal organ evaluation, inflammation mapping, and identifying toxin-related fibrosis patterns.

“This is the Star Trek future,” Goetze said, noting that modern POCUS can be used in rigs, med units, and firehouses for quick assessment and triage—without invasive procedures.


Montecito’s Key Question: “How Do We Get Toxins Out of Our Firefighters?”

Battalion Chief Shaun Davis—head of the department’s Safety Committee—cut to the central dilemma:
“We know what’s in us. We know exposure is inevitable. But what do we do about it? What actually gets it out of us?”   This question marks a national gap many fire departments face. Prevention and PPE improvements help, but they cannot remove absorbed toxins already accumulating in organs, tissues, and endocrine systems.

Davis outlined the department’s three-part approach:

1.     Prevention – minimizing exposure via PPE practices and decontamination.

2.     Post-incident Decon – showers, gear isolation, and cleaning protocols.

3.     Post-exposure Treatment – the missing puzzle piece: effective detox methods that work.

 

This is where DETOXSCAN and its encyclopedic toxicology database offered what Davis called “the next piece we’ve been missing.” The DETOXSCAN.org platform catalogs:

·        known environmental and occupational toxins,

·        scientifically supported detox modalities,

·        clinical technologies,

·        global protocols including niacin-induced detoxification, sauna-based programs, and integrative methods.

Root explained how DETOXSCAN’s evidence-driven framework aligns with F.A.C.E.S.’ core mission: prevention, early detection, and real-world recovery solutions for firefighters.

 

The Evidence Firefighters Need: Real Detoxification in Action

To answer Davis’s question about what actually removes toxins, Root presented dramatic evidence from the Root Method detox program: A New York narcotics officer who had conducted over 200 meth-lab raids sweated out visible chemical compounds during sauna-based detox sessions—enough to discolor towels in vibrant patterns confirmed as residues such as sodium hydroxide (Drāno). “These are the kinds of toxins inside the body that can come out,” Root explained.

Firefighters in wildfire regions, meth-lab response, hazmat incidents, and structure fires experience similar exposures, making such detox outcomes directly relevant. Although Montecito firefighters are currently undergoing a Level 1 detox program at Dr. Montoya’s clinic, Root noted the availability of a Level 3 full 30-day detox protocol—a complete mobilization-and-elimination methodology used for decades in occupational medicine.


Building A Local Framework: Montecito Fire Positions Itself as a First-Mover

Chief Neels emphasized the advantage of being a Fire District—which grants him greater administrative flexibility and the authority to implement innovative programs quickly. “We can pivot and we can make things happen here,” he affirmed.


 

The department’s next steps, as outlined by Neels and Davis, include:

·        reviewing feedback from the six firefighters currently participating in Dr. Montoya’s program,

·        evaluating the potential integration of OligoScan and POCUS,

·        expanding education on exposure risks and detox solutions,

·        coordinating with the department’s medical director and national experts like Dr. Jeff Burgess (Firefighter Cancer Cohort Study).

Neels also requested further information, reports, and case studies on OligoScan accuracy and adoption in U.S. and international fire departments.


A Collaborative Future: Firefighters Deserve Options—And Proof

The meeting concluded with a shared commitment to collaboration, transparency, and scientific rigor. Goetze emphasized that every article, newsletter segment, and educational publish will be fully approved by the department before release. “We just want to save lives—just like you do,” he said. “Whatever you need, we are here.”

Chief Neels reciprocated, noting the value of having partners who can bring credible, vetted solutions to the table. Davis expressed eagerness to connect further with Root to align detox strategies with emerging national research. In a field where cancer remains the #1 killer of firefighters, Montecito Fire’s proactive stance—and the partnership with DETOXSCAN, F.A.C.E.S., and Dr. Leslie Valle Montoya—marks a powerful shift toward a new model: measurement, mitigation, detoxification, and early detection.

This meeting represents a landmark step in redefining firefighter health protection for the next generation.




 SUPPLEMENTAL NEWS:

The Next Battle in Occupational Exposure: Detecting and Mitigating Heavy Metals

By: Dr. Robert L. Bard

I have spent years scanning for cancer—breast, thyroid, prostate, liver, lymphatic disease—and for inflammatory conditions that often precede malignancy. In that process, I have met hundreds of first responders who did everything right on the job, yet were never warned about the long-term biological cost of service. What has become increasingly clear to me—especially over the past year—is that heavy metal toxicity is the next sensible, unavoidable frontier in occupational medicine.

Through the growth and application of DetoxScan.org, we have been able to evaluate individuals who appear “clinically normal” on the surface, yet demonstrate alarming internal burdens of mercury, lead, cadmium, arsenic, aluminum, and other metals. These findings are not isolated. They are patterned. And they correlate strongly with occupational exposure narratives I hear every day.

From Camp Lejeune veterans exposed to contaminated water, to burn-pit exposure in Iraq and Afghanistan, to Vietnam-era Agent Orange, to firefighters working plastics-heavy modern fires and Ground Zero responders from 9/11—one recurring pathogenic thread emerges: metals that accumulate silently and persist for decades.

Heavy metals are not benign. They are neurotoxins, endocrine disruptors, mitochondrial poisons, and immune modulators. Clinically, they are associated with chronic fatigue, cognitive decline, tremors, neuropathy, thyroid dysfunction, cardiovascular disease, autoimmune disorders, infertility, mood disturbances, and increased cancer susceptibility. These are not abstract theories—they are findings we see repeatedly when exposure history is paired with modern screening.

What has changed—and what gives me great optimism—is access to non-invasive screening technologies, including spectrophotometry and light-based tissue analysis. These tools allow us to assess metal burden safely, rapidly, and without radiation or invasive sampling. When paired with diagnostic imaging, laboratory studies, and clinical history, they expand our investigative lens dramatically.

As a self-described cancer detective, I can say this plainly: these technologies don’t just give us answers—they teach us which questions to ask next. They help connect unexplained inflammation, metabolic dysfunction, and neurological symptoms to tangible, measurable causes.

Early cancer detection saved countless lives. I believe early toxic burden detection will do the same. If we truly want to protect those who protect us, this is the battle we must now fight—with vigilance, intelligence, and better tools than ever before.



SEE COMPLETE FEATURE

THE OCCUPATIONAL FACE OF MALE BREAST CANCER

Industrial Exposures, Cancer Risk, and the Need for Greater Occupational Health Awareness A Two-Part Editorial Feature for the Male Breast...